Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;49(7):731-739.
doi: 10.3899/jrheum.220038. Epub 2022 Apr 15.

Gout and Hospital Admission for Ambulatory Care-Sensitive Conditions: Risks and Trajectories

Affiliations

Gout and Hospital Admission for Ambulatory Care-Sensitive Conditions: Risks and Trajectories

Ali Kiadaliri et al. J Rheumatol. 2022 Jul.

Abstract

Objective: To investigate the risks and trajectories of hospital admission for ambulatory care-sensitive conditions (ACSCs) in gout.

Methods: Among individuals aged 35 years to 85 years residing in Skåne, Sweden, in 2005, those with no doctor-diagnosed gout during 1998 to 2005 (n = 576,659) were followed from January 1, 2006, until a hospital admission for an ACSC, death, relocation outside Skåne, or December 31, 2016. Treating a new gout diagnosis (International Classification of Diseases, 10th revision, code M10) as a time-varying exposure, we used Cox proportional and additive hazard models to estimate the effects of gout on hospital admissions for ACSCs. We investigated the trajectory of hospital admissions for ACSCs from 3 years before to 3 years after gout diagnosis using generalized estimating equations and group-based trajectory modeling in an age-and sex-matched cohort study.

Results: Gout was associated with a 41% increased rate of hospital admission for ACSCs (hazard ratio 1.41, 95% CI 1.35-1.47), corresponding to 121 (95% CI 104-138) more hospital admissions for ACSCs per 10,000 person-years compared with those without gout. Our trajectory analysis showed that higher rates of hospital admission for ACSCs among persons with gout were observed from 3 years before to 3 years after diagnosis, with the highest prevalence rate ratio (2.22, 95% CI 1.92-2.53) at the 3-month period after diagnosis. We identified 3 classes with distinct trajectories of hospital admissions for ACSCs among patients with gout: almost none (88.5%), low-rising (9.7%), and moderate-sharply rising (1.8%). The Charlson Comorbidity Index was the most important predictor of trajectory class membership.

Conclusion: Increased risk of hospital admissions for ACSCs in gout highlights the need for better management of the disease through outpatient care, especially among foreign-born, older patients with comorbidities.

Keywords: ambulatory care; gout; heterogeneity; hospitalization; longitudinal study; population registers.

PubMed Disclaimer

Conflict of interest statement

ME has received honorarium for serving on a 1-day advisory board (November 26, 2018) for Pfizer (tanezumab). All other authors declare no conflict of interest relevant to this article.

Figures

Figure 1.
Figure 1.
Prevalence rate ratio (95% CIs) for hospital admission for ambulatory care–sensitive conditions among patients with gout compared with age- and sex-matched controls without gout.
Figure 2.
Figure 2.
Distinct trajectory classes of hospital admission for ambulatory care–sensitive conditions among patients with gout starting from 3 years prior to 3 years after diagnosis (observed: symbols, estimated: solid line). Class 1: almost none; class 2: low-rising; class 3: moderate-sharply rising).

Similar articles

References

    1. Wändell P, Carlsson AC, Ljunggren G. Gout and its comorbidities in the total population of Stockholm. Prev Med 2015;81:387–91. - PubMed
    1. Kapetanovic MC, Hameed M, Turkiewicz A, et al. Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective. RMD Open 2016;2:e000326. - PMC - PubMed
    1. Shields GE, Beard SM. A systematic review of the economic and humanistic burden of gout. Pharmacoeconomics 2015;33:1029–47. - PubMed
    1. Kiadaliri AA, Englund M. Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015. Clin Rheumatol 2018;37:825–30. - PMC - PubMed
    1. Kiadaliri AA, Uhlig T, Englund M. Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015. Scand J Rheumatol 2018;47:410–7. - PubMed

Publication types